Special Message to Matrion Early Access Clinicians
Welcome to the Future of Wound Healing!
We look forward to talking more with you during our Virtual Kick-Off at 6 p.m. Wednesday, Nov. 11.
Now Available. VertiGraft ACIS VG2™
VertiGraft ACIS VG2™
Structural
A cortical-cancellous structural allograft for ACDF with the high quality and proven clinical success you depend on from the global leader in fusion and cellular therapies
Education Portal
.png)
ARTHROFLEX®
Matrion™ Placental Membrane
Exceptional Handling.
The World's Most Advanced ADM for Wounds
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology. Matracell removes a minimum of 97% of donor DNA1, allowing for rapid cellular infiltration and re-vascularization. Dermacell AWM is terminally sterilized, ready to use without refrigeration or re-hydration.
ViviGen Clinician Case Presentations
Richard S. Yoon, MD
Director of Orthopaedic Research at Jersey City Medical Center, Barnabas Health
Use of ViviGen® Cellular Bone Allograft in Orthopaedic Trauma.
Do We Even Need Iliac Crest Anymore?
ViviGen Clinician Perspective
Hear from three surgeons on their experience with using ViviGen in their patients.
Extremities
Dr. Joseph S. Park, University of Virginia
Spine
Dr. John Hall, Flagstaff Bone and Joint
Trauma
ViviGen Technology
ViviGen is the first cellular allograft to focus on recovering, processing, and protecting viable, lineage committed bone cells. It is comprised of viable, cryopreserved corticocancellous bone matrix and demineralized bone. These three components of ViviGen provide the properties necessary for bone repair that include osteoinductive signals, osteoconductive bone scaffolds, and osteogenic cells.